Summit Midstream Corporation (NYSE: SMC) ("Summit", "SMC" or the "Company") announced today its financial and operating results ...

As a result of these efforts, we're pleased to announce today that we have recently achieved the preclinical milestones, resulting in $20 million payment that we expect ... pathogenic Th1 T cells ...